Т-regulatory cells in atopic dermatitis immune response
نویسندگان
چکیده
منابع مشابه
Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
PURPOSE Regulatory T (Treg) cells are key modulators in the immune system. Recent studies have shown that atopic dermatitis (AD) patients have higher numbers of Treg cells; however, little is known about the specific phenotype and function of Treg cells in AD. MATERIALS AND METHODS To identify differentially expressed proteins in peripheral induced Treg cells in AD and naturally derived Treg ...
متن کاملCommon Allergens in Patients with Atopic Dermatitis
Abstract Background and objective: Being exposed to different allergens, followed by the production of specific IgE, has an important role in causing atopic dermatitis, recognizing the allergens and applying immunotherapy for treatment. We aimed to determine the frequency of common allergens in the patients suffering from atopic dermatitis. Material and Methods: In this descriptive- anal...
متن کاملCytokines and T cells in atopic dermatitis.
Atopic dermatitis (AD) is an inflammatory disorder of the skin characterized by an impaired immune response. Several effector T cell subsets, such as pro-inflammatory cells like Th9, Th17 and Th22 cells, expressing high levels of IL-9, IL-17 and IL-22, together with the anti-inflammatory, immuno-modulating Treg cells constitutively producing IL-10, seem to play a role in this condition. IL-9 an...
متن کاملIntravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
Many trials have been done on steroid-resistant atopic dermatitis. Recently, intravenous immune globulin (i.v.IG) was reported to be effective in the treatment of steroid-dependent atopic dermatitis. The aim of this study was to clarify whether i.v.IG therapy is effective in steroid-resistant atopic dermatitis. Forty-one steroid-resistant atopic dermatitis patients were tested in this study. Pa...
متن کاملATOPIC DERMATITIS AND ALLERGIC SKIN DISEASE Pollen Grains Induce a Rapid and Biphasic Eczematous Immune Response in Atopic Eczema Patients
METHODS. Individual patients were randomly assigned to undergo prospective HLA-B*5701 screening, with exclusion of previously known HLA-B*5701 positive patients from abacavir treatment, or to undergo a standard approach of abacavir use without screening. All subjects who started abacavir were observed for 6 weeks, the time frame in which a large majority of hypersensitivity reactions occur. The...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bulletin of Siberian Medicine
سال: 2011
ISSN: 1819-3684,1682-0363
DOI: 10.20538/1682-0363-2011-4-82-88